Dana-Farber, Beth Israel Deaconess Medical Center To Partner On $1.7B Cancer Hospital

Boston-based Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center are building a new 688,100-square-foot freestanding cancer hospital for adults, according to bizjournals.com.

The new 300-bed facility will connect to Dana-Farber’s existing facility in Boston.

As part of the project, Dana-Farber plans to relocate 30 inpatient beds from a facility that it currently shares with Brigham and Women’s Hospital in Boston.

The post Dana-Farber, Beth Israel Deaconess Medical Center To Partner On $1.7B Cancer Hospital first appeared on HCD Magazine.



Comments

Popular posts from this blog

Harlem Public Health Lab Tops Out In New York

Northside Gwinnett’s Moves Forward On Patient Tower

2023 HCD Conference Preview: The Next Generation Of Medical Malls